Jun Ohwada

Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802)

Kazutomo Kinoshita, Kohsuke Asoh, Noriyuki Furuichi et al. · Bioorganic & Medicinal Chemistry · 2011 · 164 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +8

The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic <i>PIK3CA</i> Mutations

Hiroshi Tanaka, Miyuki Yoshida, Hiromi Tanimura et al. · Clinical Cancer Research · 2011 · 98 citations

Medicine, Oncology, Pharmacology +16

9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors

Kazutomo Kinoshita, Takamitsu Kobayashi, Kohsuke Asoh et al. · Journal of Medicinal Chemistry · 2011 · 84 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole

Jun Ohwada, Masao Tsukazaki, Tadakatsu Hayase et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 82 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +15

Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799

Jun Ohwada, Hirosato Ebiike, Hatsuo Kawada et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 71 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14